BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Biotech Beach

  GenomeDx Biosciences’ Genomic Data Featured at 2018 AUA Conference in Multiple Prostate and Bladder Cancer Presentations

  -- Presentations Highlight Versatility of Decipher Tests and Decipher GRID Technology Platform --

  May 10, 2018

   · 

  4 min read
• Business

  Sierra Oncology Reports First Quarter Results

  $133.8 million cash expected to fund programs through approximately mid-2020

  May 10, 2018

   · 

  14 min read
• Business

  RXi Pharmaceuticals Reports First Quarter 2018 Financial Results and Recent Corporate Highlights

  Reduced cash burn per quarter by 20% from $2.5 million to $2 million

  May 10, 2018

   · 

  12 min read
• Business

  Kala Pharmaceuticals Reports First Quarter 2018 Financial Results

  Focus during the first quarter of 2018 has been on strengthening commercial team ahead of the potential FDA approval for INVELTYS

  May 10, 2018

   · 

  9 min read
• Biotech Bay

  Centers for Medicare and Medicaid Services Approves Reimbursement for BioCardia’s CardiAMP Cell Therapy in Pivotal Clinical Trial Studying Second Indication in Chronic Myocardial Ischemia

  Medicare reimbursement in the pivotal trial of the CardiAMP Cell Therapy System significantly enhances the Company’s ability to complete this important trial

  May 10, 2018

   · 

  6 min read
• Business

  Syros Reports First Quarter 2018 Financial Results and Highlights Key Accomplishments and Upcoming Milestones

  Presented Preclinical Data on SY-1365 Showing Potent Anti-Tumor Activity in Multiple Models of Heavily Pretreated Ovarian Cancer

  May 10, 2018

   · 

  10 min read
• Business

  New Grants Totaling $2.6 Million Fund Work to Reduce Immunotherapy Side Effects

  American Cancer Society and Melanoma Research Alliance Fund Five Innovative Approaches

  May 10, 2018

   · 

  5 min read
• Drug Development

  NeuClone Announces Preclinical Results for Stelara® (ustekinumab) Biosimilar Candidate

  Biopharmaceutical company NeuClone has announced positive preclinical results of its biosimilar to Johnson & Johnson’s Stelara®, including 3-dimensional (3-D) structure confirmation through X-ray crystallography analysis.

  May 10, 2018

   · 

  2 min read
• Business

  Biostage Reports 2018 First Quarter Financial Results

  Steady progress in the new year signals strengthening financial and technology positions

  May 10, 2018

   · 

  21 min read
• BioCapital

  Sentara RMH Medical Center Partners with Omnicell to Enhance Efficiency, Safety in Central Pharmacy Operations

  Leveraging Automation Frees Staff to Focus on Clinical Care [10-May-2018] Sentara RMH Medical Center Partners with Omnicell to Enhance Efficiency, Safety in Central Pharmacy Operations Leveraging Automation Frees Staff to Focus on Clinical Care MOUNTAIN VIEW,

  May 10, 2018

   · 

  4 min read